AVGR Stock Overview
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) in the United States and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Avinger, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$3.10 |
52 Week High | US$18.00 |
52 Week Low | US$2.50 |
Beta | 1.3 |
1 Month Change | -12.21% |
3 Month Change | 14.35% |
1 Year Change | -73.69% |
3 Year Change | -99.34% |
5 Year Change | -99.89% |
Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Avinger GAAP EPS of -$0.94 beats by $0.15, revenue of $2.13M misses by $0.25M
Aug 11Is Avinger (NASDAQ:AVGR) Using Debt Sensibly?
Nov 25Is Avinger (NASDAQ:AVGR) A Risky Investment?
Jun 30Avinger shares fall after Q1 results fail to impress Wall Street
May 07Does Avinger (NASDAQ:AVGR) Have A Healthy Balance Sheet?
Jan 21Avinger 'Hot Penny Stock to buy' - Robinhood
Jan 08Shareholder Returns
AVGR | US Medical Equipment | US Market | |
---|---|---|---|
7D | 6.1% | 2.3% | 0.2% |
1Y | -73.7% | 12.8% | 28.1% |
Return vs Industry: AVGR underperformed the US Medical Equipment industry which returned 13.3% over the past year.
Return vs Market: AVGR underperformed the US Market which returned 28.8% over the past year.
Price Volatility
AVGR volatility | |
---|---|
AVGR Average Weekly Movement | 26.6% |
Medical Equipment Industry Average Movement | 7.7% |
Market Average Movement | 6.1% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: AVGR's share price has been volatile over the past 3 months.
Volatility Over Time: AVGR's weekly volatility (27%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2007 | 70 | Jeff Soinski | https://avinger.com |
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company’s lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, including Ocelot and Tigereye, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients.
Avinger, Inc. Fundamentals Summary
AVGR fundamental statistics | |
---|---|
Market cap | US$4.66m |
Earnings (TTM) | -US$18.32m |
Revenue (TTM) | US$7.65m |
0.6x
P/S Ratio-0.3x
P/E RatioIs AVGR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AVGR income statement (TTM) | |
---|---|
Revenue | US$7.65m |
Cost of Revenue | US$5.65m |
Gross Profit | US$2.00m |
Other Expenses | US$20.32m |
Earnings | -US$18.32m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -11.55 |
Gross Margin | 26.18% |
Net Profit Margin | -239.41% |
Debt/Equity Ratio | -230.5% |
How did AVGR perform over the long term?
See historical performance and comparison